Assertio Holdings Inc
ASRT0.748USD
-0.003-0.35%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
71.93MCap. mercado
PérdidaP/E TTM
Más Datos de Assertio Holdings Inc Compañía
Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).
Información de Assertio Holdings Inc
Símbolo de cotizaciónASRT
Nombre de la empresaAssertio Holdings Inc
Fecha de salida a bolsaFeb 12, 1997
Director ejecutivoMr. Brendan P. O'Grady
Número de empleados58
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 12
Dirección100 S. Saunders Road
CiudadLAKE FOREST
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal60045
Teléfono12244197106
Sitio Webhttps://www.assertiotx.com/
Símbolo de cotizaciónASRT
Fecha de salida a bolsaFeb 12, 1997
Director ejecutivoMr. Brendan P. O'Grady
Ejecutivos de Assertio Holdings Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
196.85K
+12.05%
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
Executive Vice President, Chief Transformation Officer
Executive Vice President, Chief Transformation Officer
167.52K
+14.47%
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
156.13K
+17.33%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
107.50K
+100.00%
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
97.28K
+123.48%
Mr. Mark L. Reisenauer
Mr. Mark L. Reisenauer
Chief Executive Officer, Director
Chief Executive Officer, Director
53.75K
--
Ms. Heather L. Mason
Ms. Heather L. Mason
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sigurd C. (Sig) Kirk
Mr. Sigurd C. (Sig) Kirk
Independent Director
Independent Director
--
--
Mr. Sravan K. Emany
Mr. Sravan K. Emany
Independent Director
Independent Director
--
--
Ms. Mary E Pietryga
Ms. Mary E Pietryga
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
196.85K
+12.05%
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
Executive Vice President, Chief Transformation Officer
Executive Vice President, Chief Transformation Officer
167.52K
+14.47%
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
156.13K
+17.33%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
107.50K
+100.00%
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
97.28K
+123.48%
Mr. Mark L. Reisenauer
Mr. Mark L. Reisenauer
Chief Executive Officer, Director
Chief Executive Officer, Director
53.75K
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
ROLVEDON
16.13M
55.19%
other
4.44M
15.20%
Sympazan
3.24M
11.10%
INDOCIN products
3.03M
10.38%
SPRIX Nasal Spray
1.98M
6.76%
Royalties and milestone revenue
400.00K
1.37%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
29.22M
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
ROLVEDON
16.13M
55.19%
other
4.44M
15.20%
Sympazan
3.24M
11.10%
INDOCIN products
3.03M
10.38%
SPRIX Nasal Spray
1.98M
6.76%
Royalties and milestone revenue
400.00K
1.37%
Estadísticas de accionistas
Actualizado: dom., 17 de ago
Actualizado: dom., 17 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
9.15%
The Vanguard Group, Inc.
4.56%
Renaissance Technologies LLC
2.93%
BlackRock Institutional Trust Company, N.A.
1.43%
Geode Capital Management, L.L.C.
1.06%
Otro
80.87%
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
9.15%
The Vanguard Group, Inc.
4.56%
Renaissance Technologies LLC
2.93%
BlackRock Institutional Trust Company, N.A.
1.43%
Geode Capital Management, L.L.C.
1.06%
Otro
80.87%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
14.08%
Investment Advisor
9.33%
Investment Advisor/Hedge Fund
3.41%
Individual Investor
2.61%
Research Firm
0.05%
Venture Capital
0.01%
Otro
70.51%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
269
25.82M
26.82%
-22.80M
2025Q2
311
28.52M
29.77%
-30.86M
2025Q1
337
28.16M
29.40%
-32.55M
2024Q4
339
31.00M
32.47%
-30.41M
2024Q3
330
33.06M
34.86%
-33.72M
2024Q2
326
40.98M
43.17%
-33.17M
2024Q1
316
48.96M
52.78%
-20.37M
2023Q4
308
49.49M
53.68%
-10.26M
2023Q3
295
49.25M
53.86%
+8.83M
2023Q2
258
36.71M
65.25%
+1.46M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Nantahala Capital Management, LLC
8.81M
9.15%
+370.31K
+4.39%
Jun 30, 2025
The Vanguard Group, Inc.
4.38M
4.56%
--
--
Jun 30, 2025
Renaissance Technologies LLC
2.82M
2.93%
+117.69K
+4.35%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.37M
1.43%
-11.56K
-0.83%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.02M
1.06%
-86.31K
-7.79%
Jun 30, 2025
Two Sigma Investments, LP
867.90K
0.9%
-357.19K
-29.16%
Jun 30, 2025
CM Management, LLC
724.38K
0.75%
+249.38K
+52.50%
Jun 30, 2025
Millennium Management LLC
694.52K
0.72%
-90.05K
-11.48%
Jun 30, 2025
Polen Capital Management, LLC
651.61K
0.68%
-129.46K
-16.57%
Sep 30, 2024
Peisert (Daniel A)
607.46K
0.63%
--
--
Mar 13, 2025
Ver más
ETFs relacionados
Actualizado: hace 7 horas
Actualizado: hace 7 horas
Nombre
Proporción
ALPS Barron's 400 ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Royce Quant Small-Cap Quality Value ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Proshares Ultra Russell 2000
0%
Lattice Hartford Multifactor Small Cap ETF
0%
Fidelity Small-Mid Multifactor ETF
0%
iShares Russell 3000 ETF
0%
Ver más
ALPS Barron's 400 ETF
Proporción0%
iShares Russell 2000 Value ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Royce Quant Small-Cap Quality Value ETF
Proporción0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
Lattice Hartford Multifactor Small Cap ETF
Proporción0%
Fidelity Small-Mid Multifactor ETF
Proporción0%
iShares Russell 3000 ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
Fecha
Tipo
Relación
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
